Senior Pre-Clinical Scientist
Oxford Martin Programme on Vaccines, University of Oxford
During my PhD studies of mammary gland development and cancer biology, it became apparent that, in many ways, cancer can be thought of as a failure of proper immunological surveillance. I consequently focused on understanding the adaptive immune response, through the use of transgenic models of disease and ENU mutagenesis.
Through these works, I have delineated adaptive immune function underpinning human disease conditions, particularly focussing on the role for T & B lymphocytes. Through my position as Pre-Clinical Immunologist at the Jenner Institute I can now apply this knowledge to rationally design and augment one of society's most powerful tool against infectious disease; vaccines.